Fund Overview

Best ideas portfolio

Based on deep fundamental research, our team has high conviction in the companies selected for this portfolio.

Focus on targeted return

Built on investments we have identified with the ability, in our view, to generate attractive returns over the longer-term.

We trade time for value

Exploits short-term volatility and poor short-term price discovery due to the fund’s longer time horizon.

SMID cap expertise

Managed by a global team with deep research expertise and strong capital allocation track record.

Investment objective

The Fund aims to outperform the MSCI ACWI SMID Cap Index (after fees and expenses and before taxes) on a rolling five-year basis.

Investment process

The Vaughan Nelson Global SMID Cap Equity team seek investments that in our view have the ability to generate attractive returns over the longer-term.

Stock selection is driven by this targeted return objective, not benchmark construction.

The investment team have a rigorous, bottom-up fundamental analysis and disciplined approach to help uncover drivers of long-term strong performance.

3 lenses for success

Undervalued earnings growth

Where the future redeployment of capital is not reflected in current valuation

Undervalued assets

Where the asset is priced at a significant discount or we identify a catalyst to close the valuation gap.

Undervalued dividend yield

Where the majority of targeted return is generated by the dividend.

Key documents

Fund Facts
The Vaughan Nelson Global Equity SMID Fund


Portfolio Managers James Eisenman, CFA, CPA
Marco Priani, CFA, CPA, FRM
Kevin Ross, CFA
Chris Wallis, CFA,CPA    Find out more
Benchmark MSCI ACWI SMID Cap Index
Inception 1 June 2022
ARSN 657 058 841
Distribution frequency Generally Annually
Performance fee Nil
(the constitution for the Fund permits a performance fee to be charged. However the RE has waived its right to charge this fee)
Management fee 1.12% per annum (inclusive of the net effect of GST)

Research and ratings

Contact your State representative for a copy of the report.



The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (IML1199AU & ASX:VNGS assigned September 2023) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines

The rating contained in this document is issued by SQM Research Pty Ltd ABN 93 122 592 036 AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

The rating issued 05/2024 is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit for ratings information and to access the full report. © 2024 Lonsec. All rights reserved.